Clinical Trial Update: Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing intraoperative versus postoperative Thymoglobulin in lung transplantation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplantation

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Lung Transplant | Phase 3 | Status: WITHDRAWN